» Articles » PMID: 18630909

Acetal-derivatized Dextran: an Acid-responsive Biodegradable Material for Therapeutic Applications

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2008 Jul 18
PMID 18630909
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Dextran, a biocompatible, water-soluble polysaccharide, was modified at its hydroxyls with acetal moieties such that it became insoluble in water but freely soluble in common organic solvents enabling its use in the facile preparation of acid-sensitive microparticles. These particles degrade in a pH-dependent manner: FITC-dextran was released with a half-life at 37 degrees C of 10 h at pH 5.0 compared to a half-life of approximately 15 days at pH 7.4. Both hydrophobic and hydrophilic cargoes were successfully loaded into these particles using single and double emulsion techniques, respectively. When used in a model vaccine application, particles loaded with the protein ovalbumin (OVA) increased the presentation of OVA-derived peptides to CD8+ T-cells 16-fold relative to OVA alone. Additionally, this dextran derivative was found to be nontoxic in preliminary in vitro cytotoxicity assays. Owing to its ease of preparation, processability, pH-sensitivity, and biocompatibility, this type of modified dextran should find use in numerous drug delivery applications.

Citing Articles

Enhanced Macrophage Uptake of Spray-Dried Phosphatidylserine-Loaded Microparticles for Pulmonary Drug Delivery Applications.

Freeman M, Parvaresh-Rizi A, Meenach S J Drug Deliv Sci Technol. 2025; 104.

PMID: 39830679 PMC: 11737435. DOI: 10.1016/j.jddst.2024.106535.


How Do Cyclodextrins and Dextrans Affect the Gut Microbiome? Review of Prebiotic Activity.

Gosciniak A, Laine E, Cielecka-Piontek J Molecules. 2024; 29(22).

PMID: 39598705 PMC: 11596334. DOI: 10.3390/molecules29225316.


Comparison of emulsion and spray methods for fabrication of rapamycin-loaded acetalated dextran microparticles.

Ehrenzeller S, Lukesh N, Stiepel R, Middleton D, Nuzzolo S, Tate A RSC Pharm. 2024; 1(4):727-741.

PMID: 39415944 PMC: 11474811. DOI: 10.1039/d4pm00054d.


Ethoxy Acetalated Dextran-Based Biomaterials for Therapeutic Applications.

Damus B, Amaeze N, Yoo E, Kaur G Polymers (Basel). 2024; 16(19).

PMID: 39408467 PMC: 11479160. DOI: 10.3390/polym16192756.


Modifying Post-Surgical Immunity: Controlled Release of TLR7/8 Agonist for Immune Mediated Clearance of Glioblastoma.

Ainslie K Res Sq. 2024; .

PMID: 39399681 PMC: 11469459. DOI: 10.21203/rs.3.rs-5024510/v1.


References
1.
Solbrig C, Saucier-Sawyer J, Cody V, Saltzman W, Hanlon D . Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells. Mol Pharm. 2007; 4(1):47-57. DOI: 10.1021/mp060107e. View

2.
Matsumoto A, Matsukawa Y, Suzuki T, Yoshino H . Drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide). J Control Release. 2005; 106(1-2):172-80. DOI: 10.1016/j.jconrel.2005.03.026. View

3.
Sun-Wada G, Wada Y, Futai M . Lysosome and lysosome-related organelles responsible for specialized functions in higher organisms, with special emphasis on vacuolar-type proton ATPase. Cell Struct Funct. 2004; 28(5):455-63. DOI: 10.1247/csf.28.455. View

4.
Doner L, Irwin P . Assay of reducing end-groups in oligosaccharide homologues with 2,2'-bicinchoninate. Anal Biochem. 1992; 202(1):50-3. DOI: 10.1016/0003-2697(92)90204-k. View

5.
Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, Kiziltepe T . Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature. 2005; 436(7050):568-72. DOI: 10.1038/nature03794. View